|
This report is submitted beyond 30 calendar days from allergan¿s receipt due to the exemption transition period.A review of the device history record has been completed.No deviations or non-conformance's noted.Device evaluation: visual analysis of the returned device identified; the weight the device within specification, white particles in the shell, crease flat and was observed after autoclave: cloudy color and bubbles.Based on the device analysis the final assessment is: no were observed openings on the device or issues related with the complaint (rupture).Reason for reoperation due to rupture.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
|